Literature DB >> 27421786

Combining machine learning and propensity score weighting to estimate causal effects in multivalued treatments.

Ariel Linden1,2, Paul R Yarnold3.   

Abstract

RATIONALE, AIMS AND
OBJECTIVES: Interventions with multivalued treatments are common in medical and health research; examples include comparing the efficacy of competing interventions and contrasting various doses of a drug. In recent years, there has been growing interest in the development of methods that estimate multivalued treatment effects using observational data. This paper extends a previously described analytic framework for evaluating binary treatments to studies involving multivalued treatments utilizing a machine learning algorithm called optimal discriminant analysis (ODA).
METHOD: We describe the differences between regression-based treatment effect estimators and effects estimated using the ODA framework. We then present an empirical example using data from an intervention including three study groups to compare corresponding effects.
RESULTS: The regression-based estimators produced statistically significant mean differences between the two intervention groups, and between one of the treatment groups and controls. In contrast, ODA was unable to discriminate between distributions of any of the three study groups.
CONCLUSIONS: Optimal discriminant analysis offers an appealing alternative to conventional regression-based models for estimating effects in multivalued treatment studies because of its insensitivity to skewed data and use of accuracy measures applicable to all prognostic analyses. If these analytic approaches produce consistent treatment effect P values, this bolsters confidence in the validity of the results. If the approaches produce conflicting treatment effect P values, as they do in our empirical example, the investigator should consider the ODA-derived estimates to be most robust, given that ODA uses permutation P values that require no distributional assumptions and are thus, always valid.
© 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  causal inference; doubly robust; inverse probability of treatment weighting; machine learning; marginal mean weighting through stratification; multivalued treatments; observational studies; propensity score

Mesh:

Year:  2016        PMID: 27421786     DOI: 10.1111/jep.12610

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  5 in total

Review 1.  Machine Learning in Causal Inference: Application in Pharmacovigilance.

Authors:  Yiqing Zhao; Yue Yu; Hanyin Wang; Yikuan Li; Yu Deng; Guoqian Jiang; Yuan Luo
Journal:  Drug Saf       Date:  2022-05-17       Impact factor: 5.228

2.  Matching on poset-based average rank for multiple treatments to compare many unbalanced groups.

Authors:  Margherita Silan; Giovanna Boccuzzo; Bruno Arpino
Journal:  Stat Med       Date:  2021-09-16       Impact factor: 2.497

Review 3.  The role of machine learning in clinical research: transforming the future of evidence generation.

Authors:  E Hope Weissler; Tristan Naumann; Tomas Andersson; Rajesh Ranganath; Olivier Elemento; Yuan Luo; Daniel F Freitag; James Benoit; Michael C Hughes; Faisal Khan; Paul Slater; Khader Shameer; Matthew Roe; Emmette Hutchison; Scott H Kollins; Uli Broedl; Zhaoling Meng; Jennifer L Wong; Lesley Curtis; Erich Huang; Marzyeh Ghassemi
Journal:  Trials       Date:  2021-08-16       Impact factor: 2.279

4.  Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride.

Authors:  Tina Kiguradze; William H Temps; Steven M Belknap; Paul R Yarnold; John Cashy; Robert E Brannigan; Beatrice Nardone; Giuseppe Micali; Dennis Paul West
Journal:  PeerJ       Date:  2017-03-09       Impact factor: 2.984

Review 5.  Artificial intelligence in COVID-19 drug repurposing.

Authors:  Yadi Zhou; Fei Wang; Jian Tang; Ruth Nussinov; Feixiong Cheng
Journal:  Lancet Digit Health       Date:  2020-09-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.